#wvcusa A novel Japanese Encephalitis Vaccine by Intercell

Jeffrey Hackman, President and CEO, Intercell USA presented yesterday at the World Vaccine Congress the latest developments of this JEV Vaccine with a favorable safety profile and global distribution strategy. Japanese Encephalitis Vaccine:  Intercell currently has a licensed product against Japanese encephalitis.  They have developed it through a partnership model.  The company has an innovative R&D group and manufacturing facilities.  …

Clinical research in emerging markets discussed now by Dr Luwy Musey from @Merck Research Laboratories at #wvcusa

Do we need to achieve levels required by regulatory agencies in developed countries? Dr Luwy Musey, Director Clinical Research, Merck Research Laboratories, delivered a presentation today at the World Vaccine Congress about clinical research in emerging markets. Dr. Musey said that the ultimate goal for new vaccines is market penetration through rapid approval of a licensing application at a reasonable …

Dr Joseph Fair from Global Viral Forecasting Institute discussed today #wvcusa: Preventing epidemics – the virus hunt continues

Today at the World Vaccine Congress, Dr Joseph Fair delivered a presentation on preventing epidemics. Dr. Fair’s group is dedicated to identifying emerging pandemics before they happen.  Dr. Fair says that we know that in Brazzaville Congo, in 1929, there were at least a few people walking around with HIV/AIDS.  If we knew then, what could we have done to …

ADITEC – Advanced technologies for #vaccine research and development

Prof. Donata Medaglini from the University of Siena presented an interesting overview of ADITEC (Advanced Immunization Technologies) at the World Vaccine Congress Lyon last October. Key topics discussed in her presentation included: •    High Impact Project  funded by EU DG Research & Innovation, Health Research •    Strategy, structure and expected impact •    Human immunology and systems biology to develop new …

#Bayer explore if plant #cell-lines can grow into the #vaccine industry leaders?

Bayer are exploring the possibility of plant cell lines as a dominant player in vaccine production.  Dr John Butler-Ransohoff the Project Manager for Plant-made Pharmaceuticals at Bayer Innovations is going to evaluate the current position of development and look at where the limiting factors and commercial opportunities lie; Why plant cell-lines are ideal for vaccine production and can address the …

#Vaccine production: #Baxter explore avian #cell-lines, but could algae hold the answer…?

In every industry their is always the endless search to find ‘the-next-BIG-thing', and cell culture vaccine production is no different!  Cell lines from African green monkey to carrots, and Chinese hamster ovary to tobacco have been investigated with varying degrees of success. Now, Baxter have published results on a novel avian cell line, while at the University of Arizona, Dr …

Using #Vero cell lines to produce #Rabies, #Rotavirus and #Dengue #vaccines

Using Vero cell lines to produce Rabies, Rotavirus and Dengue vaccines is being explored and exploited at the in Brazil. The benefits of using cell culture for vaccine production to meet pandemic demands are well documented and the reason behind huge financial investment, cell culture can and is being used to produce a wide range of vaccines and exhibiting even …